Showing results (41-50 of 116) with videos related to

Sort By:
Pageof 12
Blood|January 12, 2011
Dichotomous regulation of GVHD through bidirectional functions of the BTLA-HVEM pathwayYukimi Sakoda, Jang-June Park, Yuming Zhao, et al.
The Journal of Clinical Investigation|February 21, 2002
Blockade of LIGHT/LTbeta and CD40 signaling induces allospecific T cell anergy, preventing graft-versus-host diseaseKoji Tamada, Hideto Tamura, Dallas Flies, et al.
Cancer Science|February 4, 2021
Anti-tumor efficacy of human anti-c-met CAR-T cells against papillary renal cell carcinoma in an orthotopic modelJun-Ich Mori, Keishi Adachi, Yukimi Sakoda, et al.
Blood|February 10, 2007
Interaction between B7-H1 and PD-1 determines initiation and reversal of T-cell anergyFumihiko Tsushima, Sheng Yao, Tahiro Shin, et al.
The Journal of Experimental Medicine|January 18, 2018
LIGHT-HVEM signaling in keratinocytes controls development of dermatitisRana Herro, Jr-Wen Shui, Sonja Zahner, et al.
Cancer Immunology, Immunotherapy : CII|August 31, 2011
Expression of anti-HVEM single-chain antibody on tumor cells induces tumor-specific immunity with long-term memoryJang-June Park, Sudarshan Anand, Yuming Zhao, et al.
NAR Cancer|May 6, 2026
Efficient gene disruption with CRISPR-Cas3 in human T cellsTomoaki Fujii, Yukimi Sakoda, Kazuto Yoshimi, et al.
Cancer Gene Therapy|March 6, 2004
Synergistic antitumor effect by coexpression of chemokine CCL21/SLC and costimulatory molecule LIGHTMasayuki Hisada, Takayuki Yoshimoto, Sadahiro Kamiya, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 24, 2011
Cutaneous and systemic plasmacytosis vs. cutaneous plasmacytic castleman disease: review and speculations about pathogenesisMaryam Haque, J Steve Hou, Katsuya Hisamichi, et al.
Scientific Reports|July 14, 2022
GM-CSF derived from the inflammatory microenvironment potentially enhanced PD-L1 expression on tumor-associated macrophages in human breast cancerKimihiro Yonemitsu, Cheng Pan, Yukio Fujiwara, et al.
Pageof 12